The functional cytotoxic T lymphocyte-associated Protein 4 49G-To-A genetic variant and risk of pancreatic cancer

Cancer

Volumn 118, Issue 19, 2012, Pages 4681-4686

  Yang, Ming ^a   Sun, Tong ^c   Zhou, Yifeng ^d   Wang, Li ^b   Liu, Li ^a   Zhang, Xiaojiao ^a   Tang, Xiaohu ^a   Zhou, Mo ^a   Kuang, Pengqun ^a   Tan, Wen ^b   Li, Hui ^b   Yuan, Qipeng ^a   Yu, Dianke ^b  

^a BEIJING UNIVERSITY OF CHEMICAL TECHNOLOGY   (China)

^b PEKING UNION MEDICAL COLLEGE   (China)

^c HARVARD MEDICAL SCHOOL   (United States)

^d MEDICAL COLLEGE OF SOOCHOW UNIVERSITY   (China)

Author keywords

association study; CTLA 4; pancreatic cancer; single nucleotide polymorphism; susceptibility

Indexed keywords

CYTOTOXIC T LYMPHOCYTE ANTIGEN 4;

ADULT; AGED; ARTICLE; CANCER RISK; CANCER SUSCEPTIBILITY; CONFIDENCE INTERVAL; CONTROLLED STUDY; DRINKING BEHAVIOR; FEMALE; GENETIC VARIABILITY; GENOTYPE; GENOTYPE ENVIRONMENT INTERACTION; HUMAN; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; PANCREAS CANCER; PRIORITY JOURNAL; RISK ASSESSMENT; SINGLE NUCLEOTIDE POLYMORPHISM; SMOKING;

ADENINE; AGE FACTORS; AGED; ALCOHOL DRINKING; ASIAN CONTINENTAL ANCESTRY GROUP; CASE-CONTROL STUDIES; CTLA-4 ANTIGEN; DIABETES COMPLICATIONS; FEMALE; GENE-ENVIRONMENT INTERACTION; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; GUANINE; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; ODDS RATIO; PANCREATIC NEOPLASMS; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK ASSESSMENT; RISK FACTORS; SEX FACTORS; SMOKING;

EID: 84866523730     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.27455     Document Type: Article

References (30)

1. Egen JG, Kuhns MS, Allison JP,. CTLA-4: new insights into its biological function and use in tumor immunotherapy. Nat Immunol. 2002; 3: 611-618.
2. Rudd CE, Schneider H,. Unifying concepts in CD28, ICOS and CTLA4 co-receptor signalling. Nat Rev Immunol. 2003; 3: 544-556.
3. Sharpe AH, Freeman GJ,. The B7-CD28 superfamily. Nat Rev Immunol. 2002; 2: 116-126.
4. Alegre ML, Frauwirth KA, Thompson CB,. T-cell regulation by CD28 and CTLA-4. Nat Rev Immunol. 2001; 1: 220-228.
5. Appleman LJ, Berezovskaya A, Grass I, Boussiotis VA,. CD28 costimulation mediates T cell expansion via IL-2-independent and IL-2-dependent regulation of cell cycle progression. J Immunol. 2000; 164: 144-151.
6. Scheipers P, Reiser H,. Fas-independent death of activated CD4(+) T lymphocytes induced by CTLA-4 crosslinking. Proc Natl Acad Sci U S A. 1998; 95: 10083-10088.
7. Puré E, Allison JP, Schreiber RD,. Breaking down the barriers to cancer immunotherapy. Nat Immunol. 2005; 6: 1207-1210.
8. Vandenborre K, Van Gool SW, Kasran A, Ceuppens JL, Boogaerts MA, Vandenberghe P,. Interaction of CTLA-4 (CD152) with CD80 or CD86 inhibits human T-cell activation. Immunology. 1999; 98: 413-421.
9. Leach DR, Krummel MF, Allison JP,. Enhancement of antitumor immunity by CTLA-4 blockade. Science. 1996; 271: 1734-1736.
10. Li D, Xie K, Wolff R, Abbruzzese JL,. Pancreatic cancer. Lancet. 2004; 363: 1049-1057.
11. Jemal A, Siegel R, Ward E, Murray T, Xu J, Thun MJ,. Cancer statistics, 2007. CA Cancer J Clin. 2007; 57: 43-66.
12. Qiu D, Kurosawa M, Lin Y, et al. JACC Study Group. Overview of the epidemiology of pancreatic cancer focusing on the JACC Study. J Epidemiol. 2005; 15 (suppl 2): S157-S167.
13. Lu XH, Wang L, Li H, Qian JM, Deng RX, Zhou L,. Establishment of risk model for pancreatic cancer in Chinese Han population. World J Gastroenterol. 2006; 12: 2229-2234.
14. Chari ST, Leibson CL, Rabe KG, Ransom J, de Andrade M, Petersen GM,. Probability of pancreatic cancer following diabetes: a population-based study. Gastroenterology. 2005; 129: 504-511.
15. Coughlin SS, Calle EE, Teras LR, Petrelli J, Thun MJ,. Diabetes mellitus as a predictor of cancer mortality in a large cohort of US adults. Am J Epidemiol. 2004; 159: 1160-1167.
16. Kwon ED, Foster BA, Hurwitz AA, et al. Elimination of residual metastatic prostate cancer after surgery and adjunctive cytotoxic T lymphocyte-associated antigen 4 (CTLA-4) blockade immunotherapy. Proc Natl Acad Sci U S A. 1999; 96: 15074-15079.
17. Thompson RH, Allison JP, Kwon ED,. Anti-cytotoxic T lymphocyte antigen-4 (CTLA-4) immunotherapy for the treatment of prostate cancer. Urol Oncol. 2006; 24: 442-447.
18. O'Mahony D, Morris JC, Quinn C, et al. A pilot study of CTLA-4 blockade after cancer vaccine failure in patients with advanced malignancy. Clin Cancer Res. 2007; 13: 958-964.
19. Royal RE, Levy C, Turner K, et al. Phase 2 trial of single agent Ipilimumab (anti-CTLA-4) for locally advanced or metastatic pancreatic adenocarcinoma. J Immunother. 2010; 33: 828-833.
20. Sun T, Zhou Y, Yang M, et al. Functional genetic variations in cytotoxic T-lymphocyte antigen 4 and susceptibility to multiple types of cancer. Cancer Res. 2008; 68: 7025-7034.
21. Zhang Y, Zhang J, Deng Y, et al. Polymorphisms in the cytotoxic T-lymphocyte antigen 4 gene and cancer risk: a meta-analysis. Cancer. 2011; 117: 4312-4324.
22. Zheng J, Yu X, Jiang L, et al. Association between the cytotoxic T-lymphocyte antigen 4 +49G > A polymorphism and cancer risk: a meta-analysis. BMC Cancer. 2010; 10: 522.
23. Sun T, Hu Z, Shen H, Lin D,. Genetic polymorphisms in cytotoxic T-lymphocyte antigen 4 and cancer: the dialectical nature of subtle human immune dysregulation. Cancer Res. 2009; 69: 6011-6014.
24. Wang L, Miao X, Tan W, et al. Genetic polymorphisms in methylenetetrahydrofolate reductase and thymidylate synthase and risk of pancreatic cancer. Clin Gastroenterol Hepatol. 2005; 3: 743-751.
25. Yang M, Sun T, Wang L, et al. Functional variants in cell death pathway genes and risk of pancreatic cancer. Clin Cancer Res. 2008; 14: 3230-3236.
26. Yang M, Guo H, Wu C, et al. Functional FEN1 polymorphisms are associated with DNA damage levels and lung cancer risk. Hum Mutat. 2009; 30: 1320-1328.
27. Geng Y, Savage SM, Razani-Boroujerdi S, Sopori ML,. Effects of nicotine on the immune response. II. Chronic nicotine treatment induces T cell anergy. J Immunol. 1996; 156: 2384-2390.
28. Romeo J, Wärnberg J, Nova E, Díaz LE, Gõmez-Martinez S, Marcos A,. Moderate alcohol consumption and the immune system: a review. Br J Nutr. 2007; 98 (suppl 1): S111-S115.
29. Johnson JD, Houchens DP, Kluwe WM, Craig DK, Fisher GL,. Effects of mainstream and environmental tobacco smoke on the immune system in animals and humans: a review. Crit Rev Toxicol. 1990; 20: 369-395.
30. Gurung P, Young BM, Coleman RA, et al. Chronic ethanol induces inhibition of antigen-specific CD8+ but not CD4+ immunodominant T cell responses following Listeria monocytogenes inoculation. J Leukoc Biol. 2009; 85: 34-43.